Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
Strong growth expected in the vaccines market, as Sanofi Pasteur and Merck continue to dominate over the next 10 years.
Published By Datamonitor
|
13 Feb 2013 |
$4500
|
Report
|
Recent approvals reinvigorate mCRPC market
Published By Datamonitor
|
18 Jan 2013 |
$4500
|
Report
|
The biologic drug market is growing at nearly twice the pace of the overall pharma market. This report forecasts microbial and mammalian contract manufacturing markets to 2017. Market dynamics and leading players are also examined.
Published By Datamonitor
|
19 Feb 2013 |
$3500
|
Report
|
Comparative efficacy data are not necessarily required for approval but are increasingly demanded by payers. Meeting the expectations of all stakeholders can be challenging, making comparator selection and trial design complex decisions.
Published By Datamonitor
|
23 Aug 2012 |
$3800
|
Report
|
High Phase II attrition is hampering the pharma industry’s ability to reach sustainable rates of innovation. More rigorous validation of new biological targets prior to clinical development is essential for increasing R&D efficiency.
Published By Datamonitor
|
28 Sep 2012 |
$3800
|
Report
|
This report discusses three key Latin American vaccines markets, Brazil, Mexico and Argentina. It analyzes the commercial and regulatory environment, guidelines, domestic and multinational competition as well as current and future indications.
Published By Datamonitor
|
19 Mar 2010 |
$3800
|
Report
|
Examination of the key issues in the treatment of sexual dysfunction, including risk factors, estimates of patient potential, overview of current and pipeline treatments, unmet needs, analysis of commercial opportunities and key stakeholder opinions.
Published By Datamonitor
|
04 Mar 2010 |
$7600
|
Report
|
This report analyzes three emerging markets, Brazil, Russia and India as targets for HIV drug manufacturers. It discusses the commercial and regulatory environment, guidelines, domestic and multinational competition as well as market entry strategies.
Published By Datamonitor
|
25 May 2010 |
$3800
|
Report
|
Datamonitor's survey of 300 respiratory experts in Brazil, India, China and the US addresses increased interest in COPD in the emerging markets. The US is included as a benchmark, providing unique insight and comparisons of COPD market dynamics.
Published By Datamonitor
|
22 Dec 2010 |
$15200
|
Report
|
Analysis of strategies and trends being employed by the leading pharmaceutical companies in order to overcome the ongoing R&D challenges, in addition to examining clinical pipelines and strategies to source new drugs.
Published By Datamonitor
|
14 May 2012 |
$5700
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.